FP-Biotin ABPP Protocol: Labeling & Detection of Serine Hydrolases

FP-biotin is a fluorophosphonate-biotin conjugate activity-based probe that covalently and irreversibly labels the active-site serine residue of serine hydrolases, enabling their enrichment and identification from complex proteomes.

Probe Class

Activity-based protein profiling (ABPP) probe

Reactive Group

Fluorophosphonate (FP) — covalent, irreversible serine trap

Affinity Handle

Biotin — enables streptavidin-based enrichment and detection

Target Enzyme Class

Serine hydrolases (serine proteases, lipases, esterases, amidases)

Typical Working Concentration

1–5 µM (to be optimized per sample type)

Detection Methods

SDS-PAGE + streptavidin-HRP Western blot; streptavidin-bead pulldown + LC-MS/MS

SKU

F1288601

Principle of FP-Biotin Activity-Based Protein Profiling

FP-biotin belongs to the fluorophosphonate (FP) family of activity-based probes (ABPs), originally developed for global profiling of serine hydrolase activities in native proteomes. The probe consists of three functional components: (1) a fluorophosphonate warhead that mimics the transition state of serine hydrolase substrates and forms a stable, covalent phosphonate ester with the catalytic serine residue; (2) a linker region that confers appropriate hydrophilicity and spacing; and (3) a biotin affinity tag that allows downstream enrichment with streptavidin-conjugated resins or detection with streptavidin-HRP.

Because the FP warhead reacts selectively with the active-site serine of competent (catalytically active) enzymes, FP-biotin reports enzyme activity rather than total protein abundance. Enzymes that are inhibited, denatured, or otherwise catalytically incompetent are not labeled, making FP-biotin a powerful tool for comparing enzyme activity states across different biological conditions, inhibitor treatments, or disease states.

Materials and Reagents

Probe: FP-biotin (Aladdin Scientific, SKU: F1288601), prepared as a stock solution in anhydrous DMSO (typically 1–10 mM). Aliquot and store at −20 °C, protected from light and moisture. Avoid repeated freeze-thaw cycles.

Biological samples (choose one or more):

• Mammalian cell lysate (prepared in non-denaturing lysis buffer, e.g., PBS + 0.1% Triton X-100, protease-inhibitor-free)
• Tissue homogenate (prepared in PBS, clarified by centrifugation at 100,000 × g)
• Recombinant enzyme solution

Buffers and reagents: PBS (pH 7.4); DMSO (anhydrous, molecular biology grade); SDS-PAGE sample loading buffer (reducing); streptavidin-HRP conjugate; blocking buffer (5% non-fat milk or BSA in TBST); standard Western blot reagents.

Optional (for competitive ABPP or pulldown): Serine hydrolase inhibitor (e.g., PMSF, MAFP); streptavidin-agarose or streptavidin-magnetic beads; LC-MS/MS-compatible elution buffer.

Equipment: Microcentrifuge; SDS-PAGE electrophoresis system; PVDF or nitrocellulose membrane transfer apparatus; chemiluminescence imager or film.

Step-by-Step Protocol

Step 1 — Proteome preparation
Lyse cells or homogenize tissue in non-denaturing lysis buffer without protease inhibitors (protease inhibitors may inactivate target enzymes). Clarify lysate by centrifugation (20,000 × g, 10 min, 4 °C). Determine protein concentration by BCA or Bradford assay. Adjust to a working concentration of 1–2 mg/mL in PBS.

Step 2 — FP-biotin labeling reaction
Add FP-biotin from DMSO stock to the proteome sample to a final concentration of 1–5 µM (final DMSO ≤ 0.5% v/v). Mix gently and incubate at 37 °C for 30–60 min with occasional mixing. Keep a vehicle control (DMSO only, no probe) in parallel. For competitive ABPP, pre-treat samples with the inhibitor of interest for 30 min at 37 °C before adding FP-biotin.

Step 3 — Reaction termination and sample preparation
Quench the reaction by adding SDS-PAGE sample loading buffer to a 1× final concentration. Heat samples at 95 °C for 5 min to denature proteins and terminate labeling.

Step 4 — SDS-PAGE separation
Load 20–40 µg total protein per lane onto an appropriate percentage polyacrylamide gel (typically 10–12%). Run at standard conditions. Include a molecular weight marker.

Step 5 — Transfer and Western blot detection
Transfer proteins to PVDF membrane. Block for 1 h at room temperature with 5% non-fat milk in TBST. Incubate with streptavidin-HRP (typically 1:5,000–1:10,000 dilution) for 1 h at room temperature. Wash 3× with TBST (10 min each). Develop with ECL substrate and image. FP-biotin–labeled serine hydrolases appear as distinct bands.

Step 6 (Optional) — Streptavidin pulldown for proteomics
After labeling (Step 2), precipitate proteins with methanol/chloroform, resolubilize in PBS + 0.2% SDS, and incubate with streptavidin-agarose beads overnight at 4 °C. Wash beads, elute with SDS loading buffer, and process eluate for LC-MS/MS identification of labeled enzymes.

Troubleshooting and Optimization Tips

High background / non-specific bands: Endogenous biotin-containing proteins (e.g., carboxylases) are a common source of background when using streptavidin-HRP. Include an unlabeled (no-probe) control lane to identify endogenous biotinylated proteins. Pre-clear lysates with streptavidin beads before labeling to reduce background. Alternatively, use an avidin pre-blocking step on the membrane.

Weak or absent signal: Increase FP-biotin concentration (up to 10 µM) or extend incubation time. Verify that the target serine hydrolase is expressed and active in the chosen sample. Ensure DMSO stock has not undergone hydrolysis — prepare fresh aliquots regularly. Confirm probe has not been stored improperly (avoid aqueous solutions for long-term storage).

Loss of enzyme activity before labeling: Do not add protease inhibitors such as PMSF to lysis buffer, as PMSF directly inhibits serine hydrolases and will abolish FP-biotin labeling. Keep samples on ice and process quickly after lysis.

DMSO toxicity in cell-based assays: For in situ (live-cell) labeling experiments, keep final DMSO concentration ≤ 0.1%. Optimize probe concentration and incubation time separately for cell-based formats.

Poor streptavidin pulldown efficiency: Ensure complete protein denaturation and resolubilization before bead incubation. Increase bead volume or incubation time. Use fresh, high-binding-capacity streptavidin beads.

Frequently asked questions

What types of enzymes does FP-biotin label?

FP-biotin selectively labels active serine hydrolases, a large enzyme superfamily that includes serine proteases, lipases, esterases, thioesterases, and amidases. The fluorophosphonate warhead reacts specifically with the catalytic serine in the enzyme active site, so only catalytically competent enzymes are labeled.

Why should I avoid protease inhibitor cocktails in my lysis buffer when using FP-biotin?

Many common protease inhibitors, particularly serine protease inhibitors such as PMSF and aprotinin, directly inhibit serine hydrolases by occupying or modifying their active-site serine. If these inhibitors are present during lysis, the target enzymes will be inactivated before FP-biotin can react with them, resulting in loss of signal. Prepare lysates without serine-directed protease inhibitors to preserve enzyme activity for labeling.

Can FP-biotin be used for in situ labeling of live cells?

Yes, FP-biotin can be applied directly to live cells or added to culture medium for in situ labeling of cell-accessible serine hydrolases. For live-cell experiments, optimize the probe concentration (typically lower than for lysate-based assays) and limit DMSO to ≤ 0.1% to minimize cytotoxicity. Incubation times and temperatures may also require optimization for each cell type.

How should FP-biotin stock solution be prepared and stored?

Dissolve FP-biotin in anhydrous DMSO to prepare a stock solution at 1–10 mM. Aliquot into single-use volumes to avoid repeated freeze-thaw cycles. Store aliquots at −20 °C, protected from light and moisture. Do not dissolve in aqueous buffers for long-term storage, as the fluorophosphonate warhead is susceptible to hydrolysis.

How can I distinguish specifically labeled bands from background endogenous biotinylated proteins?

Always run a no-probe (DMSO vehicle) control lane alongside your FP-biotin–treated samples. Any bands present in both the probe-treated and vehicle-control lanes represent endogenous biotinylated proteins, not FP-biotin–labeled serine hydrolases. Bands appearing exclusively in the probe-treated lane represent specifically labeled enzymes.

References

1. Liu Y, Patricelli MP, Cravatt BF. Activity-based protein profiling: the serine hydrolases. Proc Natl Acad Sci USA. 1999;96(26):14694–14699. doi:10.1073/pnas.96.26.14694
2. Cravatt BF, Wright AT, Kozarich JW. Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annu Rev Biochem. 2008;77:383–414. doi:10.1146/annurev.biochem.75.101304.124125
3. Jessani N, Cravatt BF. The development and application of methods for activity-based protein profiling. Curr Opin Chem Biol. 2004;8(1):54–59. doi:10.1016/j.cbpa.2003.11.004

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.